{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T03:24:31Z","timestamp":1787109871087,"version":"build-2736575974"},"reference-count":28,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2010,2,1]],"date-time":"2010-02-01T00:00:00Z","timestamp":1264982400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,2,1]],"date-time":"2010-02-01T00:00:00Z","timestamp":1264982400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T00:00:00Z","timestamp":1787097600000},"content-version":"vor","delay-in-days":6043,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Anales de Pediatr\u00eda"],"published-print":{"date-parts":[[2010,2]]},"DOI":"10.1016\/j.anpedi.2009.10.011","type":"journal-article","created":{"date-parts":[[2009,12,22]],"date-time":"2009-12-22T04:08:26Z","timestamp":1261454906000},"page":"103-110","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Rasburicasa versus alopurinol como tratamiento de la hiperuricemia en el s\u00edndrome de lisis tumoral"],"prefix":"10.1016","volume":"72","author":[{"given":"V.","family":"S\u00e1nchez Tatay","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.D.","family":"L\u00f3pez Castilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.M.","family":"Carmona Ponce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.M.","family":"P\u00e9rez Hurtado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Quiroga Cantero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Loscertales Abril","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.anpedi.2009.10.011_bib1","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1002\/pbc.20555","article-title":"Recombinant urate oxidase (rasburicase) for the treatment of hyperuricemia in pediatric patients with hematologic malignancies: Results of a compassionate prospective multicenter study in Korea","volume":"46","author":"Shin","year":"2006","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.anpedi.2009.10.011_bib2","unstructured":"Solano P, P\u00e9rez-Hurtado JM. S\u00edndrome de lisis tumoral. En: M\u00e1rquez C, Ram\u00edrez GL. Manual de urgencias de Oncolog\u00eda Pedi\u00e1trica. Grupo Acci\u00f3n M\u00e9dica; 2006. p. 3\u201313"},{"key":"10.1016\/j.anpedi.2009.10.011_bib3","unstructured":"Hande KR. Hyperuricemia, uric acid nephropathy and the tumor lysis syndrome. En: McKinney TD, editor. Renal complications of neoplasia. Praeger; 1986. p. 134\u201356"},{"key":"10.1016\/j.anpedi.2009.10.011_bib4","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/S0022-3476(86)80387-0","article-title":"Purine excretion during tumor lysis in children with acute lymphocytic leukemia receiving allopurinol: Relationship to acute renal failure","volume":"109","author":"Andreoli","year":"1986","journal-title":"J Pediatr"},{"key":"10.1016\/j.anpedi.2009.10.011_bib5","doi-asserted-by":"crossref","first-page":"2998","DOI":"10.1182\/blood.V97.10.2998","article-title":"A randomized comparison between rasburicase and allopurinol in children with lymphoma or leukemia at high risk for tumor lysis","volume":"97","author":"Goldman","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.anpedi.2009.10.011_bib6","doi-asserted-by":"crossref","first-page":"2767","DOI":"10.1200\/JCO.2007.15.0177","article-title":"Guidelines for the management of paediatrics and adult tumor lysis syndrome: An evidence\u2013based review","volume":"26","author":"Coiffier","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.anpedi.2009.10.011_bib7","doi-asserted-by":"crossref","first-page":"905a","DOI":"10.1182\/blood.V104.11.3312.3312","article-title":"Low dose recombinant urate oxidase (rasburicase) is effective in hyperuricemia","volume":"104","author":"Trifilio","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.anpedi.2009.10.011_bib8","doi-asserted-by":"crossref","first-page":"3123a","DOI":"10.1182\/blood.V106.11.3123.3123","article-title":"Low dose recombinant urate oxidase (rasburicase) is effective in treating hyperuricemia in patients with hematologic malignancies","volume":"106","author":"Trifilio","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.anpedi.2009.10.011_bib9","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1200\/JCO.2001.19.3.697","article-title":"Recombinant urate oxidase for the prophylaxis or treatment of hyperuricemia in patients with leukemia or lymphoma","volume":"19","author":"Pui","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.anpedi.2009.10.011_bib10","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1038\/sj.leu.2400850","article-title":"Urate oxidase in prevention and treatment of hyperuricemia associated with lymphoid malignancies","volume":"11","author":"Pui","year":"1997","journal-title":"Leukemia"},{"key":"10.1016\/j.anpedi.2009.10.011_bib11","first-page":"924","article-title":"Rasburicase prevents tumor lysis syndrome despite extreme hyperleukocytosis","volume":"19","author":"Robyn","year":"2004","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.anpedi.2009.10.011_bib12","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/BF02893442","article-title":"Prevention and treatment of hyperuricemia with rasburicase in children with leukemia and non-Hodgkin's limphoma","volume":"13","author":"Renyi","year":"2007","journal-title":"Pathol Oncol Res"},{"key":"10.1016\/j.anpedi.2009.10.011_bib13","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1002\/cncr.11612","article-title":"Rasburicase (recombinant urate oxidase) for the management of hyperuricemia in patients with cancer","volume":"98","author":"Bosly","year":"2003","journal-title":"Cancer"},{"key":"10.1016\/j.anpedi.2009.10.011_bib14","article-title":"Efficacy and safety of rasburicase, a recombinant urate oxidase (Elitek\u2122), in the management of malignancy-associated hyperuricemia in pediatric and adult patients: Final results of a multicenter compassionate use trial","volume":"19","author":"Jhea","year":"2005","journal-title":"Leukemia"},{"key":"10.1016\/j.anpedi.2009.10.011_bib15","doi-asserted-by":"crossref","first-page":"4402","DOI":"10.1200\/JCO.2003.04.115","volume":"21","author":"Bertrand","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.anpedi.2009.10.011_bib16","first-page":"141","article-title":"Efficacy and safety of recombinant urate oxidase (rasburicase) for treatment and prophylaxis of hyperuricemia in children undergoing chemotherapy","volume":"90","author":"Pession","year":"2005","journal-title":"Haematologica"},{"key":"10.1016\/j.anpedi.2009.10.011_bib17","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1159\/000089463","article-title":"Recombinant urate oxidase (rasburicase) for the prevention and treatment of tumor lysis syndrome in patients with hematologic malignancies","volume":"115","author":"Wang","year":"2006","journal-title":"Acta Haematol"},{"key":"10.1016\/j.anpedi.2009.10.011_bib18","doi-asserted-by":"crossref","first-page":"83","DOI":"10.7150\/ijms.4.83","article-title":"Rasburicase represents a new tool for hyperuricemia in tumor lysis syndrome and in gout","volume":"4","author":"Cammalleri","year":"2007","journal-title":"Int J Med Sci"},{"key":"10.1016\/j.anpedi.2009.10.011_bib19","first-page":"679","article-title":"Avoiding dialysis in tumor lysis syndrome: Is urate oxidase effective? A case report and review of literature","volume":"36","author":"Wan-Ye","year":"2007","journal-title":"Ann Acad Med"},{"key":"10.1016\/j.anpedi.2009.10.011_bib20","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1157\/13089935","article-title":"Single-dose rasburicase as treatment for tumor lysis sindrome in two patients","volume":"64","author":"Ferrandis Rodr\u00edguez","year":"2006","journal-title":"An Pediatr"},{"key":"10.1016\/j.anpedi.2009.10.011_bib21","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1592\/phco.26.6.806","article-title":"Single-dose rasburicase 6mg in the management of tumor lysis syndrome in adults","volume":"26","author":"McDonnell","year":"2006","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.anpedi.2009.10.011_bib22","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1592\/phco.26.2.242","article-title":"Reduced-dose rasburicase in the treatment of adults with hyperuricemia associated with malignancy","volume":"26","author":"Hutcherson","year":"2006","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.anpedi.2009.10.011_bib23","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.leukres.2004.09.004","article-title":"A single-dose of rasburicase is sufficient for the treatment of hyperuricemia in patients receiving chemotherapy","volume":"29","author":"Liu","year":"2005","journal-title":"Leuk Res"},{"key":"10.1016\/j.anpedi.2009.10.011_bib24","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1345\/aph.1E002","article-title":"Use of single-dose rasburicase in an obese female","volume":"38","author":"Arnold","year":"2004","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.anpedi.2009.10.011_bib25","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1345\/aph.1D111","article-title":"Treatment of impending tumor lysis with single-dose rasburicase","volume":"37","author":"Lee","year":"2003","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.anpedi.2009.10.011_bib26","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1111\/j.1600-0609.2007.01013.x","article-title":"Effective treatment and prophylaxis of hyperuricemia and impaired renal function in tumor lysis syndrome with low dose of rasburicase","volume":"80","author":"Hummel","year":"2008","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.anpedi.2009.10.011_bib27","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/j.1365-2710.2008.00994.x","article-title":"Single dose rasburicase for tumour lysis syndrome in adults: Weight based approach","volume":"34","author":"Campera","year":"2009","journal-title":"J Clin Pharm Ther"},{"key":"10.1016\/j.anpedi.2009.10.011_bib28","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1097\/MPH.0b013e318162bd41","article-title":"SFCE (Soci\u00e9t\u00e9 fran\u00c7aise de lutte contre les cancers et leuc\u00e9mies de l\u2032enfant et l\u2032adolescent) recommendations for the management of tumor lysis syndrome (TLS) with rasburicase: An observational survey","volume":"30","author":"Bertrand","year":"2008","journal-title":"J Pediatr Hematol Oncol"}],"container-title":["Anales de Pediatr\u00eda"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1695403309006109?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1695403309006109?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T02:29:04Z","timestamp":1787106544000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1695403309006109"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,2]]},"references-count":28,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,2]]}},"alternative-id":["S1695403309006109"],"URL":"https:\/\/doi.org\/10.1016\/j.anpedi.2009.10.011","relation":{},"ISSN":["1695-4033"],"issn-type":[{"value":"1695-4033","type":"print"}],"subject":[],"published":{"date-parts":[[2010,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rasburicasa versus alopurinol como tratamiento de la hiperuricemia en el s\u00edndrome de lisis tumoral","name":"articletitle","label":"Article Title"},{"value":"Anales de Pediatr\u00eda","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anpedi.2009.10.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 Asociaci\u00f3n Espa\u00f1ola de Pediatr\u00eda. Published by Elsevier Espa\u00f1a, S.L. All rights reserved.","name":"copyright","label":"Copyright"}]}}